A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

CHMP recommends EU approval of Roche’s Alecensa as the first adjuvant treatment for resected ALK-positive early-stage lung cancer
Published: April 26, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
Media Update: New data presented at ATS demonstrate Sanofi’s leadership in advancing potential new therapies for patients with immune-mediated respiratory diseases
Published: April 26, 2024 by Sanofi SA
'Tim-3 Antagonists For The Treatment And Diagnosis Of Cancers' in Patent Application Approval Process (USPTO 20240117044)
Published: April 25, 2024 by NewsRx Pharma Business Daily
FDA accepts for priority review GSK’s application for an expanded indication of Jemperli dostarlimab-gxly plus chemotherapy to include all adult patients with primary advanced or recurrent endometrial cancer
Published: April 24, 2024 by GSK Group (GlaxoSmithKline)
US Patent Issued to Regeneron Pharmaceuticals on April 23 for "Antigen binding molecule formats" (New York Inventors)
Published: April 24, 2024 by U.S. Fed News

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count